Stifel Financial Corp Denali Therapeutics Inc. Transaction History

Stifel Financial Corp

  • $93.2 Billion
  • Q3 2024

A detailed history of Stifel Financial Corp transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 9,839 shares of DNLI stock, worth $237,907. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,839
Previous 12,847 23.41%
Holding current value
$237,907
Previous $298,000 4.03%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$20.96 - $31.05 $63,047 - $93,398
-3,008 Reduced 23.41%
9,839 $286,000
Q2 2024

Aug 13, 2024
SELL
$14.96 - $23.22 $388 - $603
-26 Reduced 0.2%
12,847 $298,000
Q1 2024

May 13, 2024
SELL
$15.83 - $23.35 $348 - $513
-22 Reduced 0.17%
12,873 $264,000
Q4 2023

Feb 12, 2024
BUY
$16.2 - $23.18 $8,764 - $12,540
541 Added 4.38%
12,895 $276,000
Q3 2023

Nov 13, 2023
SELL
$20.63 - $30.17 $18,670 - $27,303
-905 Reduced 6.83%
12,354 $254,000
Q2 2023

Aug 14, 2023
SELL
$23.37 - $32.96 $6,263 - $8,833
-268 Reduced 1.98%
13,259 $391,000
Q1 2023

May 12, 2023
BUY
$21.91 - $32.67 $2,629 - $3,920
120 Added 0.9%
13,527 $311,000
Q4 2022

Feb 13, 2023
SELL
$26.28 - $33.92 $3,705 - $4,782
-141 Reduced 1.04%
13,407 $372,000
Q3 2022

Nov 14, 2022
BUY
$25.97 - $38.53 $14,491 - $21,499
558 Added 4.3%
13,548 $415,000
Q2 2022

Aug 15, 2022
SELL
$20.88 - $35.19 $13,572 - $22,873
-650 Reduced 4.77%
12,990 $383,000
Q1 2022

May 13, 2022
SELL
$29.0 - $47.27 $435 - $709
-15 Reduced 0.11%
13,640 $439,000
Q4 2021

Feb 14, 2022
SELL
$42.59 - $55.02 $43,101 - $55,680
-1,012 Reduced 6.9%
13,655 $609,000
Q3 2021

Nov 15, 2021
BUY
$48.48 - $78.23 $78,392 - $126,497
1,617 Added 12.39%
14,667 $740,000
Q2 2021

Aug 13, 2021
BUY
$50.3 - $78.44 $4,225 - $6,588
84 Added 0.65%
13,050 $1.02 Million
Q1 2021

May 14, 2021
BUY
$53.8 - $81.53 $374,179 - $567,041
6,955 Added 115.7%
12,966 $740,000
Q4 2020

Feb 12, 2021
SELL
$36.89 - $93.56 $9,591 - $24,325
-260 Reduced 4.15%
6,011 $503,000
Q3 2020

Nov 16, 2020
BUY
$23.13 - $38.84 $145,048 - $243,565
6,271 New
6,271 $225,000
Q2 2020

Aug 14, 2020
SELL
$16.01 - $28.82 $218,072 - $392,557
-13,621 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$14.2 - $27.98 $24,509 - $48,293
1,726 Added 14.51%
13,621 $236,000
Q4 2019

Feb 13, 2020
BUY
$14.4 - $19.99 $4,608 - $6,396
320 Added 2.76%
11,895 $207,000
Q2 2019

Aug 14, 2019
BUY
$18.5 - $28.14 $214,137 - $325,720
11,575 New
11,575 $240,000

Others Institutions Holding DNLI

# of Institutions
228
Shares Held
120M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.24B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email